MedTrace Logo

Immune Responses Induced by Different Licensed Influenza Vaccines

NCT00902278 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 193

Last updated 2017-11-20

Study results available
· View outcomes & findings →

Summary

The goal of this research is to find out how the body's immune system responds to different manufacturer's "flu" vaccines.

Conditions

  • Immune Response

Interventions

BIOLOGICAL

Flulaval

one 0.5-mL dose via intramuscular injection

BIOLOGICAL

Fluvirin

one 0.5-mL dose via intramuscular injection

BIOLOGICAL

Fluzone

one 0.5-mL dose via intramuscular injection

BIOLOGICAL

Fluarix

one 0.5-mL dose via intramuscular injection

BIOLOGICAL

Afluria

one 0.5-mL dose via intramuscular injection

Sponsors & Collaborators

  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Mary Dawn T Co, MD · University of Massachusetts, Worcester

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00902278 on ClinicalTrials.gov